{
    "2021-03-31": [
        [
            {
                "time": "2021-03-31",
                "original_text": "健帆生物2020年度净利同比增53% 拟10派6.6元",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "2020年度",
                        "净利",
                        "同比增53%",
                        "10派6.6元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-31",
                "original_text": "健帆生物(300529.SZ)拟续聘致同会计师事务所为2021年度审计机构",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "续聘",
                        "致同会计师事务所",
                        "2021年度审计机构"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-31",
                "original_text": "健帆生物(300529.SZ)2020年度归母净利同比升53.33%至8.75亿元 拟10派6.6元",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "2020年度",
                        "归母净利",
                        "同比升53.33%",
                        "8.75亿元",
                        "10派6.6元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-31",
                "original_text": "健帆生物(300529.SZ)2020年度净利润升53.33%至8.75亿元 拟10派6.6元",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "2020年度",
                        "净利润",
                        "升53.33%",
                        "8.75亿元",
                        "10派6.6元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-31",
                "original_text": "健帆生物：2020年度净利润约8.75亿元，同比增长53.33%",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "2020年度",
                        "净利润",
                        "8.75亿元",
                        "同比增长53.33%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-31",
                "original_text": "健帆生物：2020年净利润同比增长53.33%",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "2020年",
                        "净利润",
                        "同比增长53.33%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}